Top Markets
Coin of the day
Orum Therapeutics, Inc. Orum Therapeutics, Inc.

Orum Therapeutics, Inc.

475830
Kedudukan dalam Saham #9664
Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the... Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic solutions for both cancer and immune system conditions. The firm specializes in creating degrader-antibody conjugates, an innovative class of drugs that merges traditional antibody-drug conjugate (ADC) technology with targeted protein degradation. Their flagship product candidate, ORM-1153, functions as a GSPT1 protein degrader, specifically engineered to address hematologic malignancies. Orum Therapeutics was established in 2016 and operates out of Daejeon, South Korea.
Harga Saham
$45.64
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$969.02M
Perubahan (1 hari)
-1.20%
Perubahan (1 tahun)
146.66%
Negara
KR
Perdagangan Orum Therapeutics, Inc. (475830)

Kategori

Harga 475830 dengan permodalan pasaran b
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
475830
$45.64
Modal pasaran bagi Orum Therapeutics, Inc.(475830)
Modal Pasaran: $969.02M
Sehingga August 2026, Orum Therapeutics, Inc. mempunyai modal pasaran sebanyak $969.02M. Ini menjadikan Orum Therapeutics, Inc. syarikat ke-9664th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Orum Therapeutics, Inc. dari 2025 hingga 2026
475830 berbanding dengan 5 teratas yang paling popular stocks
Harga 475830 Aset B Pasaran B Hasilnya
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$247,917 $969.02M
$5.264T +543,118.35%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$221,420 $969.02M
$4.701T +485,060.24%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$196,736 $969.02M
$4.177T +430,974.59%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$179,792 $969.02M
$3.817T +393,846.51%
Orum Therapeutics, Inc. Orum Therapeutics, Inc.
$134,998 $969.02M
$2.866T +295,698.99%